Joana Vidal

Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patients

Joana Vidal, Laura Muinelo, Alba Dalmases et al. · Annals of Oncology · 2017 · 352 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer

Beth O. Van Emburgh, Sabrina Arena, Giulia Siravegna et al. · Nature Communications · 2016 · 211 citations · Full text

Medicine, Oncology, Pharmacology +17

Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer

Julieta Grasselli, Elena Élez, Ginevra Caratù et al. · Annals of Oncology · 2017 · 194 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses

Clara Montagut, Guillem Argilés, Fortunato Ciardiello et al. · JAMA Oncology · 2018 · 144 citations · Full text

Medicine, Oncology, Pharmacology +17

Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD 1402 Trial

Joana Vidal, David Casadevall, Beatríz Bellosillo et al. · Clinical Cancer Research · 2021 · 94 citations · Full text

Medicine, Oncology, Surgery +17